Balasuriya, Lilanthi
Quinton, Jacob K.
Canavan, Maureen E.
Holland, Margaret L.
Edelman, E. Jennifer
Druss, Benjamin G.
Ross, Joseph S.
Article History
Received: 1 February 2021
Accepted: 16 June 2021
First Online: 17 August 2021
Declarations
:
: Dr. Balasuriya is supported by the Yale National Clinician Scholars Program and U.S. Department of Veterans Affairs (VA) Office of Academic Affiliations through the VA/National Clinician Scholars Program and Yale University. These views do not in any capacity represent the federal government or the VA.Dr. Quinton is supported through the UCLA National Clinician Scholars Program, Department of Medicine, and CTSI grant number 5TL1TR001883-04 and consults for UnitedHealthcare not related to this work or publication.In the past 36 months, Dr. Ross has received research support through Yale University from Johnson and Johnson to develop methods of clinical trial data sharing, from Medtronic, Inc. and the Food and Drug Administration (FDA) to develop methods for postmarket surveillance of medical devices (U01FD004585), from the Food and Drug Administration to establish Yale-Mayo Clinic Center for Excellence in Regulatory Science and Innovation (CERSI) program (U01FD005938), from the Blue Cross Blue Shield Association to better understand medical technology evaluation, from the Centers of Medicare and Medicaid Services (CMS) to develop and maintain performance measures that are used for public reporting (HHSM-500-2013-13018I), from the Agency for Healthcare Research and Quality (R01HS022882), from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) (R01HS025164), and from the Laura and John Arnold Foundation to establish the Good Pharma Scorecard at Bioethics International and to establish the Collaboration for Research Integrity and Transparency (CRIT) at Yale.
Free to read: This content has been made available to all.